Community-Acquired Pneumonia Treatment Guidelines
Introduction to Treatment
- The American Thoracic Society recommends combination therapy with a beta-lactam antibiotic plus a macrolide for community-acquired pneumonia, with treatment duration of 5-7 days for non-severe cases and 10-14 days for severe cases 1, 2, 3
Treatment Based on Severity and Setting
- For non-severe community-acquired pneumonia, the Infectious Diseases Society of America recommends amoxicillin monotherapy as the preferred agent for patients who can be managed in the community 4
- For penicillin-allergic patients, a macrolide is recommended as an alternative 4
- Treatment duration should be 7 days for uncomplicated community-managed pneumonia 2, 4
- Oral therapy is appropriate from the beginning for ambulatory patients 3, 5
- For severe community-acquired pneumonia, immediate parenteral antibiotic administration is required 2, 3
- An intravenous combination of a broad-spectrum β-lactamase stable antibiotic together with a macrolide is preferred 2, 3, 6
Special Considerations
- Patients should be switched from intravenous to oral therapy when they are hemodynamically stable and improving clinically 1
- Minimum treatment duration should be 5 days 1, 4
- Patient should be afebrile for 48-72 hours before discontinuation 1, 4
Monitoring Response to Treatment
- Monitor response using simple clinical criteria, including body temperature 2, respiratory parameters 4, and hemodynamic parameters 3, 5
- C-reactive protein should be measured on days one and three/four, especially in patients with unfavorable clinical parameters 3, 5